These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14744499)

  • 1. Mechanism of action of 2-methoxyestradiol: new developments.
    Mooberry SL
    Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.
    Mooberry SL
    Curr Opin Oncol; 2003 Nov; 15(6):425-30. PubMed ID: 14624224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
    Mabjeesh NJ; Escuin D; LaVallee TM; Pribluda VS; Swartz GM; Johnson MS; Willard MT; Zhong H; Simons JW; Giannakakou P
    Cancer Cell; 2003 Apr; 3(4):363-75. PubMed ID: 12726862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity.
    Chua YS; Chua YL; Hagen T
    Mol Cancer Ther; 2010 Jan; 9(1):224-35. PubMed ID: 20053769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease.
    Parada-Bustamante A; Valencia C; Reuquen P; Diaz P; Rincion-Rodriguez R; Orihuela PA
    Mini Rev Med Chem; 2015; 15(5):427-38. PubMed ID: 25723461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
    Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
    Kamath K; Okouneva T; Larson G; Panda D; Wilson L; Jordan MA
    Mol Cancer Ther; 2006 Sep; 5(9):2225-33. PubMed ID: 16985056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression.
    Muh CR; Joshi S; Singh AR; Kesari S; Durden DL; Makale MT
    J Neurooncol; 2014 Jan; 116(1):89-97. PubMed ID: 24162827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice.
    Schaible EV; Windschügl J; Bobkiewicz W; Kaburov Y; Dangel L; Krämer T; Huang C; Sebastiani A; Luh C; Werner C; Engelhard K; Thal SC; Schäfer MK
    J Neurochem; 2014 Jun; 129(6):940-54. PubMed ID: 24606183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer agent 2-methoxyestradiol improves survival in septic mice by reducing the production of cytokines and nitric oxide.
    Yeh CH; Chou W; Chu CC; So EC; Chang HC; Wang JJ; Hsing CH
    Shock; 2011 Nov; 36(5):510-6. PubMed ID: 21841536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.
    Peyrat JF; Brion JD; Alami M
    Curr Med Chem; 2012; 19(24):4142-56. PubMed ID: 22709003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol.
    Hagen T; D'Amico G; Quintero M; Palacios-Callender M; Hollis V; Lam F; Moncada S
    Biochem Biophys Res Commun; 2004 Sep; 322(3):923-9. PubMed ID: 15336552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma.
    Lin H; Jiang X; Zhu H; Jiang W; Dong X; Qiao H; Sun X; Jiang H
    Tumour Biol; 2016 Jan; 37(1):381-91. PubMed ID: 26219898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia.
    Zhe N; Chen S; Zhou Z; Liu P; Lin X; Yu M; Cheng B; Zhang Y; Wang J
    Cancer Biol Ther; 2016 Jun; 17(6):625-34. PubMed ID: 27082496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats.
    Yan J; Chen C; Lei J; Yang L; Wang K; Liu J; Zhou C
    Exp Neurol; 2006 Dec; 202(2):348-56. PubMed ID: 16904108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway.
    LaVallee TM; Zhan XH; Johnson MS; Herbstritt CJ; Swartz G; Williams MS; Hembrough WA; Green SJ; Pribluda VS
    Cancer Res; 2003 Jan; 63(2):468-75. PubMed ID: 12543804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors.
    Dahut WL; Lakhani NJ; Gulley JL; Arlen PM; Kohn EC; Kotz H; McNally D; Parr A; Nguyen D; Yang SX; Steinberg SM; Venitz J; Sparreboom A; Figg WD
    Cancer Biol Ther; 2006 Jan; 5(1):22-7. PubMed ID: 16357512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer drug 2-methoxyestradiol protects against renal ischemia/reperfusion injury by reducing inflammatory cytokines expression.
    Chen YY; Yeh CH; So EC; Sun DP; Wang LY; Hsing CH
    Biomed Res Int; 2014; 2014():431524. PubMed ID: 25229058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of 2-methoxyestradiol-induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells.
    Mabjeesh NJ; Shefler A; Amir S; Matzkin H
    Prostate; 2008 May; 68(6):679-89. PubMed ID: 18288682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.